Iterum Therapeutics
ITRM
#10097
Rank
NZ$42.62 M
Marketcap
NZ$0.81
Share price
2.04%
Change (1 day)
-76.37%
Change (1 year)

Earnings for Iterum Therapeutics (ITRM)

Earnings in 2025 (TTM): -NZ$36.19 Million

According to Iterum Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$37.87 Million, an increase over its 2023 earnings that were of -NZ$62.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Iterum Therapeutics from 2017 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$36.19 Million-4.45%
2024 -NZ$37.87 Million-39.41%
2023 -NZ$62.51 Million-13.03%
2022 -NZ$71.87 Million-51.03%
2021 -NZ$0.15 Billion135.87%
2020 -NZ$62.22 Million-64.48%
2019 -NZ$0.18 Billion33.65%
2018 -NZ$0.14 Billion159.97%
2017 -NZ$50.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion 589.06%๐Ÿ‡บ๐Ÿ‡ธ USA